Latest KFF Health News Stories
¿Por qué más adultos mayores no reciben los refuerzos contra covid?
Según los CDC, aproximadamente 1 de cada 3 estadounidenses mayores de 65 años que completaron su ronda inicial de vacunación aún no han recibido la primera vacuna de refuerzo. Investigadores enfatizan que este grupo sigue teniendo el mayor riesgo de enfermedad grave y muerte por covid-19.
Is Paxlovid, the Covid Pill, Reaching Those Who Most Need It? The Government Won’t Say
Many public health workers are unable to see how many doses of Pfizer’s antiviral treatment are shipped to their communities and cannot tell whether vulnerable residents are filling prescriptions as often as their wealthier neighbors.
Why Won’t More Older Americans Get Their Covid Booster?
Approximately 1 in 3 Americans 65 and older who completed their initial vaccination round still have not received a first booster shot. The numbers dismay researchers, who say the lag has cost tens of thousands of lives.
Sweeping, Limited, or No Powers at All? What’s at Stake in the Mask Mandate Appeal
Dictionaries, public comments, and even an old court case that involved underwear pricing could play a role as the government appeals a ruling that sharply limits federal authority during pandemics.
KHN’s ‘What the Health?’: More Covid Complications for Congress
Congress is back in session, but covid diagnoses for Vice President Kamala Harris and two Democratic senators have temporarily left the Senate without a working majority to approve continued covid funding. Meanwhile, opponents of the Affordable Care Act have filed yet another lawsuit challenging a portion of the law, and we say goodbye to the late Sen. Orrin Hatch of Utah, who left a long legacy of health laws. Rachel Cohrs of STAT News, Anna Edney of Bloomberg News, and Rebecca Adams of KHN join KHN’s Julie Rovner to discuss these issues and more.
Judge’s Ruling on the CDC Mask Mandate Highlights the Limits of the Agency’s Power
A recent court decision that overturns one of the Centers for Disease Control and Prevention’s few pandemic rules — masks required on public transportation — spotlights how little power remains in federal hands to enforce public health protections.
Readers and Tweeters Sound Alarm Over Nurse’s Homicide Trial
KHN gives readers a chance to comment on a recent batch of stories.
KHN’s ‘What the Health?’: News You Might Have Missed
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Babies Die as Congenital Syphilis Continues a Decade-Long Surge Across the US
Congenital syphilis rates keep climbing, according to newly released federal data. But the primary funding source for most public health departments has been largely stagnant, its purchasing power dragged even lower by inflation.
Colorado Moves Toward Statewide Coverage of Wastewater Surveillance
Colorado was among the first states to embrace wastewater testing to track the coronavirus, an important public heath intervention that can give early warning of outbreaks.
KHN’s ‘What the Health?’: Finally, a Fix for the ‘Family Glitch’
President Joe Biden welcomed former President Barack Obama back to the White House this week to announce a new policy for the Affordable Care Act that would make subsidies available to more families with unaffordable employer coverage. Meanwhile, Congress struggled to find a compromise for continued federal funding of covid-19 vaccines, testing, and treatments. Tami Luhby of CNN, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
Por qué adultos mayores de minorías no reciben la vacuna de alta dosis contra la gripe
Esta vacuna reforzada contra la influenza, podría ser más efectiva contra el virus, pero es más costosa. Y no suele estar disponible para las poblaciones más vulnerables.
Why Black and Hispanic Seniors Are Left With a Less Powerful Flu Vaccine
Federal health officials haven’t taken a clear position on whether a high-dose influenza vaccine — on the market since 2010 — is the best choice for people 65 and older. Many in that group already opt for the costlier enhanced shot. Those who get the standard vaccine are disproportionately members of ethnic and racial minorities.
Los retrasos en el diagnóstico y tratamiento del autismo aumentaron durante la pandemia
La pandemia retrasó muchos servicios médicos críticos, entre ellos los del autismo. Estos tratamientos son esenciales para los niños recién diagnosticados.
Delays for Autism Diagnosis and Treatment Grew Even Longer During the Pandemic
Despite increased public awareness, research advances, and wider insurance coverage for autism therapies, children often wait months — in some cases more than a year — to get an autism diagnosis and begin intervention services. The waits can be longer for Black and Latino children, and families in rural areas are also disadvantaged, without access to providers.
At a Tennessee Crossroads, Two Pharmacies, a Monkey, and Millions of Pills
Prosecutors say opioid-seeking patients drove hours to get their prescriptions filled in Celina, Tennessee, where pharmacies ignored signs of substance misuse and paid cash — or “monkey bucks” — to keep customers coming back.
Pfizer CEO Pushes Yearly Shots for Covid. Not So Fast, Experts Say.
A corporate CEO’s call for a fourth mRNA shot struck those closely watching the pandemic as self-serving. It creates public pressure for a fourth dose of vaccine before government experts have time to assess the evidence and settle on the best course forward.
Readers and Tweeters Remain Vigilant on Masking and Billing
KHN gives readers a chance to comment on a recent batch of stories.
KHN’s ‘What the Health?’: Congress Shelves Covid Funding for Now
The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
The CDC’s New Guidelines on Covid Risk and Masking Send Confounding Signals
The agency’s updated recommendations lower the level of covid risk for most of the country and therefore the need to mask. But some experts question the strategy.
